466 results
Recurrent and residual tricuspid regurgitation after transcatheter repair - Assessment and management
26 Nov 2024 – From PCR London Valves 2024
Join us as we delve into the critical topic of recurrent and residual tricuspid regurgitation after transcatheter repair. Gain valuable insights on how to avoid these complications, learn to assess the underlying mechanisms and severity, and explore the latest options for interventional treatment. This session, developed...
Transcatheter tricuspid valve replacement - The fundamentals
26 Nov 2024 – From PCR London Valves 2024
Interested in learning the key steps for successful transcatheter tricuspid valve replacement?
Join this session to refine your skills in patient selection, procedural planning and execution. You'll explore a real-world case of a 62-year-old patient with heart failure symptoms and gain insights from the TRISCEND II study.
How to implement a successful structural intervention programme
26 Nov 2024 – From PCR London Valves 2024
Embark on a journey to learn how to implement a successful structural intervention program. Discover the essential requirements for building transcatheter valve intervention capabilities, including the necessary equipment, personnel, and training programs. Gain insights on establishing aortic, mitral, and tricuspid intervention programs, as well as creating...
Bicaval TricValve in severe tricuspid regurgitation: one-year outcomes from the Tricbicaval Registry
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion between Angel Sanchez Recalde and Fernando Sarnago, discover the latest updates from the Tricbicaval Registry, as experts discuss the TricValve system for managing severe tricuspid regurgitation. Learn about the patient profiles included in the registry, its promising initial results, and how it...
TRISCEND II Pivotal Trial : How will TTVR impact the treatment of tricuspid regurgitation?
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Marianna Adamo, Philipp Lurz, and Sam Dawkins explore the one-year outcomes of the TRISCEND II Pivotal Trial, highlighting its potential to redefine the management of severe tricuspid regurgitation. They delve into the trial’s impact on patients’ quality of life, examine its limitations,...
Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair
29 Apr 2025 – From PCR London Valves 2024
Curious about the latest advancements in transcatheter tricuspid valve interventions? Don't miss this discussion between Philipp Lurz and Lukas Stolz as they delve into the topic of residual tricuspid regurgitation after transcatheter repair—a challenge that still needs improvement despite significant progress.
This interview was filmed at PCR...
What is the future role of 3D ICE in tricuspid valve intervention?
26 Nov 2024 – From PCR London Valves 2024
Discover insights on imaging in tricuspid valve management in this engaging PCR London Valves 2024 roundtable discussion with Jennifer Franke, Felix Kreidel, and Azeem Latib.
Explore the potential of 3D intracardiac echocardiography as a cutting-edge tool for advanced imaging, set to transform clinical practice as it adoption...
Tricuspid valve disease: PCR London Valves 2024 highlights
26 Nov 2024 – From PCR London Valves 2024
Nicolo Piazza and Fabien Praz join Christopher Cook to highlight the key takeaways from the latest presentations on the tricuspid valve.They evoke the new research and scientific evidence that will have an impact on clinical practice, the rapidly evolving technical innovations and the challenges facing tricuspid...
Insights from real-world and post-market evidence on Tricuspid TEER
26 Nov 2024 – From PCR London Valves 2024
In this video, Mirjam Wild, Tobias Kister, and Jonathan Byrne discuss real-world evidence from transcatheter edge-to-edge repair, focusing on the TriCLASP and PACE registries. These studies evaluate the PASCAL Precision system for tricuspid regurgitation and its impact on clinical practice.
This interview was filmed at PCR London...
What do we know about bleeding risk & antithrombotic management after tricuspid valve interventions?
26 Nov 2024 – From PCR London Valves 2024
How do we navigate the thin line between bleeding risk and thrombosis in high-risk patients undergoing tricuspid valve interventions? Marianna Adamo and Fabien Praz explore the latest strategies in anticoagulation, the challenges of managing complex cases and how cutting-edge research is shaping the future of care....
